Next Science Limited

ASX:NXS Voorraadrapport

Marktkapitalisatie: AU$39.4m

Next Science Beheer

Beheer criteriumcontroles 0/4

De CEO Next Science is I.V. Hall, benoemd in Jul2023, heeft een ambtstermijn van 1.33 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 418.38K, bestaande uit 47.6% salaris en 52.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.23% van de aandelen van het bedrijf, ter waarde A$ 89.79K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.5 jaar en 1.3 jaar.

Belangrijke informatie

I.V. Hall

Algemeen directeur

US$418.4k

Totale compensatie

Percentage CEO-salaris47.6%
Dienstverband CEO1.3yrs
Eigendom CEO0.2%
Management gemiddelde ambtstermijn1.5yrs
Gemiddelde ambtstermijn bestuur1.3yrs

Recente managementupdates

Recent updates

Take Care Before Jumping Onto Next Science Limited (ASX:NXS) Even Though It's 36% Cheaper

Oct 22
Take Care Before Jumping Onto Next Science Limited (ASX:NXS) Even Though It's 36% Cheaper

Further Upside For Next Science Limited (ASX:NXS) Shares Could Introduce Price Risks After 29% Bounce

Jul 26
Further Upside For Next Science Limited (ASX:NXS) Shares Could Introduce Price Risks After 29% Bounce

It's Down 32% But Next Science Limited (ASX:NXS) Could Be Riskier Than It Looks

Jun 08
It's Down 32% But Next Science Limited (ASX:NXS) Could Be Riskier Than It Looks

Will Next Science (ASX:NXS) Spend Its Cash Wisely?

Apr 16
Will Next Science (ASX:NXS) Spend Its Cash Wisely?

Further Upside For Next Science Limited (ASX:NXS) Shares Could Introduce Price Risks After 26% Bounce

Mar 06
Further Upside For Next Science Limited (ASX:NXS) Shares Could Introduce Price Risks After 26% Bounce

Potential Upside For Next Science Limited (ASX:NXS) Not Without Risk

Dec 26
Potential Upside For Next Science Limited (ASX:NXS) Not Without Risk

Next Science Limited (ASX:NXS) Analysts Just Trimmed Their Revenue Forecasts By 10%

Oct 26
Next Science Limited (ASX:NXS) Analysts Just Trimmed Their Revenue Forecasts By 10%

Take Care Before Jumping Onto Next Science Limited (ASX:NXS) Even Though It's 26% Cheaper

May 13
Take Care Before Jumping Onto Next Science Limited (ASX:NXS) Even Though It's 26% Cheaper

The Next Science Limited (ASX:NXS) Analysts Have Been Trimming Their Sales Forecasts

Feb 03
The Next Science Limited (ASX:NXS) Analysts Have Been Trimming Their Sales Forecasts

Here's Why We're Not Too Worried About Next Science's (ASX:NXS) Cash Burn Situation

Jan 25
Here's Why We're Not Too Worried About Next Science's (ASX:NXS) Cash Burn Situation

Next Science Limited (ASX:NXS) Is Expected To Breakeven In The Near Future

Mar 07
Next Science Limited (ASX:NXS) Is Expected To Breakeven In The Near Future

Here's Why We're Watching Next Science's (ASX:NXS) Cash Burn Situation

Feb 14
Here's Why We're Watching Next Science's (ASX:NXS) Cash Burn Situation

Did Next Science Limited (ASX:NXS) Insiders Buy Up More Shares?

Jan 18
Did Next Science Limited (ASX:NXS) Insiders Buy Up More Shares?

Do Institutions Own Next Science Limited (ASX:NXS) Shares?

Dec 20
Do Institutions Own Next Science Limited (ASX:NXS) Shares?

What Type Of Returns Would Next Science's(ASX:NXS) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Nov 23
What Type Of Returns Would Next Science's(ASX:NXS) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Analyse CEO-vergoeding

Hoe is I.V. Hall's beloning veranderd ten opzichte van Next Science's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$14m

Mar 31 2024n/an/a

-US$15m

Dec 31 2023US$418kUS$199k

-US$16m

Compensatie versus markt: De totale vergoeding ($USD 418.38K ) I.V. } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 297.98K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van I.V. te vergelijken met de prestaties van het bedrijf.


CEO

I.V. Hall

1.3yrs

Tenure

US$418,378

Compensatie

Mr. Harry Thomas Hall, IV, also known as I.V., has been Managing Director and Chief Executive Officer at Next Science Limited since July 10, 2023. He serves as Director at Next Science Limited since July 1...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Harry Hall
MD, CEO & Director1.3yrsUS$418.38k0.23%
A$ 89.8k
Matthew Myntti
Founder & CTOno dataUS$413.71k1.43%
A$ 563.2k
Marc Zimmerman
Chief Financial Officer1.5yrsUS$343.34k0.051%
A$ 20.2k
Jon Swanson
Chief Operating Officer6.4yrsUS$298.60k0.017%
A$ 6.7k
Robert Bell
Senior Vice President of North American Salesless than a yeargeen gegevensgeen gegevens
Gillian Nairn
Company Secretary6.4yrsgeen gegevensgeen gegevens

1.5yrs

Gemiddelde duur

Ervaren management: Het managementteam van NXS wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Harry Hall
MD, CEO & Director1.3yrsUS$418.38k0.23%
A$ 89.8k
Grant Hummel
Independent Non-Executive Director1.3yrsUS$21.45k0.13%
A$ 52.3k
Aileen Stockburger
Independent Non-Executive Chairman6.1yrsUS$111.85k0.19%
A$ 76.9k
Katherine Ostin
Independent Non-Executive Director1.1yrsUS$12.66kgeen gegevens

1.3yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van NXS wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw bestuur.